Eye exams recommended before and during treatment The AOA advises patients to undergo a comprehensive, dilated eye exam either within the year prior to starting a GLP-1 drug or within one month of beginning therapy
This indicates that BMT contributed to significant improvements in overall sexual function
Like NAD+, Glutathione production can naturally decline with age, as well as chronic stress, pollution exposure and poor diet
Changes to testosterone and estrogen balances are apparent in stages like infancy, puberty, and even older adulthood

More serious but less common adverse effects require clinical vigilance: Pancreatitis : Patients should be counselled to stop the medication and seek immediate medical attention if they experience severe, persistent abdominal pain radiating to the back [1] [5] Gallbladder disease : Rapid weight loss associated with GLP-1 therapy may increase cholelithiasis risk [1] Hypoglycaemia : Particularly when used alongside insulin or sulphonylureas in diabetes management Diabetic retinopathy : Semaglutide requires caution in patients with pre-existing retinopathy, who should be monitored regularly [1] Renal impairment : Dehydration from gastrointestinal side effects may affect kidney function Specific considerations for individuals with eating disorders include the potential for GLP-1 medications to exacerbate restrictive eating patterns or mask hunger cues in vulnerable individuals